COST-MINIMIZATION ANALYSIS OF ADDING A NEW SINGLE INHALER TRIPLE THERAPY (SITT) FOR THE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN THE UK

被引：1
|
作者：
Schroeder, M. [1 ]
Shah, D. [2 ]
Risebrough, N. [3 ]
Ndirangu, K. [2 ]
Martin, A. A. [4 ]
Ismaila, A. [5 ]
机构：
[1] GSK, Brentford, England
[2] ICON Plc, New York, NY USA
[3] ICON Plc, ICON Hlth Econ, Toronto, ON, Canada
[4] GSK, Uxbridge, Middx, England
[5] GSK, Res Triangle Pk, NC USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.1595
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PR532
引用
收藏
页码：S235 / S235
页数：1
相关论文
共 50 条
  • [1] BUDGET IMPACT OF ADDING A NEW SINGLE INHALER TRIPLE THERAPY (SITT) FOR THE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN THE UK
    Shah, D.
    Schroeder, M.
    Martin, A. A.
    Risebrough, N.
    Ndirangu, K.
    Ismaila, A.
    VALUE IN HEALTH, 2018, 21 : S232 - S233
  • [2] COST-EFFECTIVENESS OF A NEW SINGLE INHALER TRIPLE THERAPY (SITT) VERSUS MULTIPLE INHALER TRIPLE THERAPIES (MITT) TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN CANADA
    Goodall, E.
    Schroeder, M.
    Lozano-Ortega, G.
    Johnston, K.
    Martin, A.
    Ismaila, A.
    VALUE IN HEALTH, 2018, 21 : S410 - S410
  • [3] A SYSTEMATIC REVIEW OF SINGLE-INHALER TRIPLE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    Langham, S.
    Lewis, J.
    Pooley, N.
    Embleton, N.
    Langham, J.
    VALUE IN HEALTH, 2019, 22 : S873 - S873
  • [4] Cost-minimization analysis of a telehomecare program for patients with chronic obstructive pulmonary disease
    Pare, Guy
    Sicotte, Claude
    St Jules, Danielle
    Gauthier, Richard
    TELEMEDICINE JOURNAL AND E-HEALTH, 2006, 12 (02): : 114 - 121
  • [5] COST-EFFECTIVENESS OF A SINGLE-INHALER TRIPLE THERAPY VS A DUAL BRONCHODILATOR FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN AUSTRALIA
    Schembri, S.
    Schroeder, M.
    Shah, D.
    Martin, A.
    Ndirangu, A.
    Risebrough, N.
    Thrasis, A.
    Bremner, P.
    Haberl, M.
    Ismaila, A.
    RESPIROLOGY, 2020, 25 : 145 - 145
  • [6] Cost-effectiveness of a Single-Inhaler Triple Therapy Versus a Dual Bronchodilator for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Australia
    Schroeder, M.
    Shah, D.
    Martin, A.
    Ndirangu, K.
    Risebrough, N.
    Thrasis, A.
    Schembri, S.
    Bremner, P.
    Haberl, M.
    Ismaila, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [7] COST-EFFECTIVENESS OF A SINGLE-INHALER TRIPLE THERAPY VS A DUAL BRONCHODILATOR FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN AUSTRALIA
    Schembri, S.
    Schroeder, M.
    Shah, D.
    Martin, A.
    Ndirangu, K.
    Risebrough, N.
    Thrasis, A.
    Bremner, P.
    Haberl, M.
    Ismaila, A.
    RESPIROLOGY, 2021, 26 : 119 - 119
  • [8] ECONOMIC EVALUATION OF SINGLE INHALER TRIPLE THERAPY FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) USING THE GALAXY MODEL
    Risebrough, N.
    Schroeder, M.
    Shah, D.
    Goodall, E.
    Ndirangu, K.
    Martin, A.
    Ismaila, A.
    VALUE IN HEALTH, 2018, 21 : S414 - S414
  • [9] ECONOMIC EVALUATION OF SINGLE INHALER TRIPLE THERAPY FOR PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) USING THE GALAXY MODEL
    Zhang, S.
    Shah, D.
    Risebrough, N.
    Marlin, A. A.
    Briggs, A.
    Ismaila, A.
    VALUE IN HEALTH, 2017, 20 (09) : A646 - A646
  • [10] Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review
    Sue Langham
    Jen Lewis
    Nick Pooley
    Nina Embleton
    Julia Langham
    MeiLan K. Han
    James D. Chalmers
    Respiratory Research, 20
12345